GSGPX
Price
$10.28
Change
+$0.03 (+0.29%)
Updated
Jun 26 closing price
Net Assets
4.85B
PASPX
Price
$10.84
Change
+$0.03 (+0.28%)
Updated
Jun 26 closing price
Net Assets
279.43M
Interact to see
Advertisement

GSGPX vs PASPX

Header iconGSGPX vs PASPX Comparison
Open Charts GSGPX vs PASPXBanner chart's image
Goldman Sachs Absolute Ret Trckr P
Price$10.28
Change+$0.03 (+0.29%)
VolumeN/A
Net Assets4.85B
PACE Alternative Strategies P
Price$10.84
Change+$0.03 (+0.28%)
VolumeN/A
Net Assets279.43M
GSGPX vs PASPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSGPX vs. PASPX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGPX is a Buy and PASPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSGPX has more cash in the bank: 4.85B vs. PASPX (279M). PASPX pays higher dividends than GSGPX: PASPX (4.58) vs GSGPX (1.13). GSGPX was incepted earlier than PASPX: GSGPX (7 years) vs PASPX (19 years). PASPX (2.62) is less costly to investors than GSGPX (0.82). PASPX is a more actively managed with annual turnover of: 368.00 vs. GSGPX (179.00). GSGPX has a lower initial minimum investment than PASPX: GSGPX (0) vs PASPX (10000). GSGPX annual gain was more profitable for investors over the last year : 5.14 vs. PASPX (3.23). GSGPX return over 5 years is better than : 21.76 vs. PASPX (12.27).
GSGPXPASPXGSGPX / PASPX
Total Expense Ratio0.732.3331%
Annual Report Gross Expense Ratio0.822.6231%
Fund Existence7 years19 years-
Gain YTD2.8083.24786%
Front LoadN/AN/A-
Min. Initial Investment010000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.85B279M1,738%
Annual Yield % from dividends1.134.5825%
Returns for 1 year5.143.23159%
Returns for 3 years20.9212.98161%
Returns for 5 years21.7612.27177%
Returns for 10 yearsN/A13.63-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LSTA2.940.42
+16.67%
Lisata Therapeutics
SBGI13.720.22
+1.59%
Sinclair
ARES171.112.31
+1.37%
Ares Management Corp
TDC21.730.15
+0.70%
TERADATA Corp
SWKH14.840.07
+0.47%
SWK Holdings Corp